New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
20:25 EDTHD, HD, MDT, MDT, TJX, TJX, SPLS, SPLS, DKS, DKS, DCI, DCI, AINV, AINV, RRGB, RRGBNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Home Depot (HD), consensus 99c; Medtronic (MDT), consensus $1.12; TJX Companies (TJX), consensus 67c; Staples (SPLS), consensus 21c; Dick's Sporting Goods (DKS), consensus 52c; Donaldson (DCI), consensus 47c; Apollo Investment (AINV), consensus 21c; Red Robin (RRGB), consensus 72c.
News For HD;MDT;TJX;SPLS;DKS;DCI;AINV;RRGB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
08:38 EDTHDHome Depot price target raised to $110 from $100 at RW Baird
Subscribe for More Information
October 30, 2014
12:35 EDTMDTMedtronic CEO sees Covidien merger closing in early 2015
Subscribe for More Information
10:09 EDTHDLowe's, Home Depot rise after Goldman says housing outlook improved
Shares of Lowe's (LOW) and Home Depot (HD) are rising after Goldman Sachs became more upbeat on both companies. The firm said that the housing sector's improved outlook made the stocks more attractive. WHAT'S NEW: Goldman Sachs analyst Matthew Fassler upgraded Lowe's to Buy from Neutral and raised his price target on the shares to $63 from $58. He increased his price target on Home Depot to $103 from $100 but kept a Neutral rating on the stock. Fassler increased his estimates for both companies to reflect his greater optimism about the housing sector in 2015-2016. The analyst said that his upgrade of Lowe's also reflects his more upbeat view of retail stocks linked to housing, given the lack of cyclical challenges facing the housing market. Furthermore, Lowe's can increase its margins significantly, as they are much further below their peak than most of the company's peer, according to Fassler. Meanwhile, the big box, Do-It-Yourself retailers face little competition from Amazon (AMZN), added the analyst. PRICE ACTION: In early trading, Lowe's climbed 0.5% to $56.09, while Home Depot rose fractionally to $96.48.
07:34 EDTMDTEnteroMedics names Brad Hancock Chief Commercial Officer
Subscribe for More Information
06:28 EDTHDLowe's upgraded to Buy from Neutral at Goldman
Goldman Sachs upgraded Lowe's (LOW) to Buy saying housing is going through a multi-year recovery. Goldman believes the large home improvement retailers have limited risk of disruption by Amazon (AMZN). It raised its price target for Lowe's shares to $63 from $58. The firm keeps a Neutral rating on Home Depot (HD) but raised its price target for shares to $103 from $100.
October 28, 2014
09:09 EDTMDTMedtronic initiates PERIGON pivotal trial
Subscribe for More Information
07:19 EDTMDTMB Venture Partners to hold a conference
Subscribe for More Information
October 27, 2014
10:32 EDTHDVeriFone rises after Barron's says Apple Pay positive for company
Subscribe for More Information
October 23, 2014
13:02 EDTDKSCabela's tumbles after results, guidance miss expectations
Subscribe for More Information
October 22, 2014
10:09 EDTTJXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:11 EDTTJXTJX downgraded to Neutral from Buy at Northcoast
Subscribe for More Information
07:21 EDTMDTU.S. DHS investigates medical gear for potential cyber defects, Reuters says
Subscribe for More Information
October 21, 2014
09:52 EDTMDTCovidien rises after Medtronic maintains merger date language
Shares of Covidien (COV) are rising in early trading after Medtronic (MDT), in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of the Irish drugmaker, left its language regarding the expected closing date unchanged. WHAT'S NEW: In its most recent filing, Medtronic again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived." ANALYST REACTION: Research firm BTIG says Medtronic's amended regulatory filing on the Covidien transaction increases the firm's confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. WHAT'S NOTABLE: AbbVie (ABBV) last night confirmed that the company and Shire (SHPG), another Irish domiciled drugmaker, agreed to terminate their proposed merger. AbbVie said its decision was based upon its assessment of the September 22 notice issued by the U.S. Department of Treasury, which re-interpreted longstanding tax principles in a "uniquely selective manner designed specifically to destroy the financial benefits of these types of transactions." AbbVie continued that the Treasury notice "introduced an unacceptable level of risk and uncertainty given the magnitude of the proposed changes" and the stated intention of the department to continue to revise tax principles to further impact such "tax inversion" transactions. AbbVie noted that it has agreed to pay Shire a break fee of approximately $1.64B due to the deal falling through. PRICE ACTION: In early trading, shares of Covidien trading in New York rose 4% to $88.86, Medtronic advanced 1% to $64.57, Shires gained 0.7% to $185.82 and AbbVie added 1.4% to $55.16.
09:43 EDTMDTAmended filing increases confidence in Covidien deal at BTIG
BTIG says Medtronic's (MDT) amended regulatory filing on the Covidien (COV) transaction increases its confidence of the deal closing by early 2015. The firm adds it would be "stunned" to see Medtronic walk away from the merger after the company again showed commitment to the acquisition. Shares of Covidien are up 3% to $88.11 in early trading.
09:11 EDTMDTMedtronic keeps language unchanged on merger closing date
Medtronic in its latest regulatory filing answering questions for shareholders regarding its proposed takeover of Covidien (COV) left the language unchanged around the expected closing date. The company again stated, "As of the date of this joint proxy statement/prospectus, the transaction is expected to be completed late in the fourth calendar quarter of 2014 or early 2015. However, no assurance can be provided as to when or if the transaction will be completed. The required vote of Medtronic and Covidien shareholders to adopt the required shareholder proposals at their respective special meetings, as well as the necessary regulatory consents and approvals, must first be obtained and other conditions specified in the conditions appendix must be satisfied or, to the extent applicable, waived."
06:22 EDTSPLS, HDStaples may be latest retailer to be hacked, Krebs reports
Subscribe for More Information
October 20, 2014
10:24 EDTSPLSStaples and Cynthia Rowley announce exclusive collaboration
Staples and designer Cynthia Rowley announce an exclusive work and home office collection that incorporates designs into everyday work and home spaces. Beginning mid-November, Staples stores nationwide will debut the exclusive Cynthia Rowley Collection.
07:20 EDTMDTInternational Continence Society to hold annual meeting
ICS Annual Meeting 2014 is being held in Rio de Janeiro, Brazil on October 20-24.
07:12 EDTMDTCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information
06:47 EDTDKSDick's Sporting shares have value at current levels, says Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use